{"id":"https://openalex.org/W4361276906","doi":"https://doi.org/10.1080/19420862.2023.2189974","title":"Structure-based engineering of a novel CD3\u03b5-targeting antibody for reduced polyreactivity","display_name":"Structure-based engineering of a novel CD3\u03b5-targeting antibody for reduced polyreactivity","publication_year":2023,"publication_date":"2023-03-29","ids":{"openalex":"https://openalex.org/W4361276906","doi":"https://doi.org/10.1080/19420862.2023.2189974","pmid":"https://pubmed.ncbi.nlm.nih.gov/36991534","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10072072"},"language":"en","primary_location":{"id":"doi:10.1080/19420862.2023.2189974","doi":"https://doi.org/10.1080/19420862.2023.2189974","is_oa":true,"landing_page_url":"https://doi.org/10.1080/19420862.2023.2189974","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/19420862.2023.2189974?needAccess=true&role=button","source":{"id":"https://openalex.org/S169123381","display_name":"mAbs","issn_l":"1942-0862","issn":["1942-0862","1942-0870"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.tandfonline.com/doi/pdf/10.1080/19420862.2023.2189974?needAccess=true&role=button","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042655964","display_name":"Catherine Y. Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210161061","display_name":"Adimab (United States)","ror":"https://ror.org/05mk27574","country_code":"US","type":"company","lineage":["https://openalex.org/I4210161061"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Catherine Y Liu","raw_affiliation_strings":["LLC","Adimab, LLC, NH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LLC","institution_ids":[]},{"raw_affiliation_string":"Adimab, LLC, NH, USA","institution_ids":["https://openalex.org/I4210161061"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076683707","display_name":"Cory L. Ahonen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210161061","display_name":"Adimab (United States)","ror":"https://ror.org/05mk27574","country_code":"US","type":"company","lineage":["https://openalex.org/I4210161061"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cory L Ahonen","raw_affiliation_strings":["LLC","Adimab, LLC, NH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LLC","institution_ids":[]},{"raw_affiliation_string":"Adimab, LLC, NH, USA","institution_ids":["https://openalex.org/I4210161061"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103191879","display_name":"Michael E. Brown","orcid":"https://orcid.org/0000-0003-3292-2117","observed_orcids":["https://orcid.org/0000-0003-3292-2117"]},"institutions":[{"id":"https://openalex.org/I4210161061","display_name":"Adimab (United States)","ror":"https://ror.org/05mk27574","country_code":"US","type":"company","lineage":["https://openalex.org/I4210161061"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael E Brown","raw_affiliation_strings":["LLC","Adimab, LLC, NH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LLC","institution_ids":[]},{"raw_affiliation_string":"Adimab, LLC, NH, USA","institution_ids":["https://openalex.org/I4210161061"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100325661","display_name":"Ling Hui Zhou","orcid":"https://orcid.org/0000-0001-9868-2561","observed_orcids":["https://orcid.org/0000-0001-9868-2561"]},"institutions":[{"id":"https://openalex.org/I4210161061","display_name":"Adimab (United States)","ror":"https://ror.org/05mk27574","country_code":"US","type":"company","lineage":["https://openalex.org/I4210161061"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ling Zhou","raw_affiliation_strings":["LLC","Adimab, LLC, NH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LLC","institution_ids":[]},{"raw_affiliation_string":"Adimab, LLC, NH, USA","institution_ids":["https://openalex.org/I4210161061"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051832282","display_name":"Martin Welin","orcid":"https://orcid.org/0000-0001-5786-1600","observed_orcids":["https://orcid.org/0000-0001-5786-1600"]},"institutions":[{"id":"https://openalex.org/I4210092524","display_name":"SARomics Biostructures (Sweden)","ror":"https://ror.org/00md1r011","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210092524"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Martin Welin","raw_affiliation_strings":["SARomics Biostructures AB","SARomics Biostructures AB, Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SARomics Biostructures AB","institution_ids":["https://openalex.org/I4210092524"]},{"raw_affiliation_string":"SARomics Biostructures AB, Lund, Sweden","institution_ids":["https://openalex.org/I4210092524"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063941096","display_name":"Eric M. Krauland","orcid":"https://orcid.org/0000-0003-0657-8412","observed_orcids":["https://orcid.org/0000-0003-0657-8412"]},"institutions":[{"id":"https://openalex.org/I4210161061","display_name":"Adimab (United States)","ror":"https://ror.org/05mk27574","country_code":"US","type":"company","lineage":["https://openalex.org/I4210161061"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric M Krauland","raw_affiliation_strings":["LLC","Adimab, LLC, NH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LLC","institution_ids":[]},{"raw_affiliation_string":"Adimab, LLC, NH, USA","institution_ids":["https://openalex.org/I4210161061"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112540180","display_name":"Robert Pejchal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210161061","display_name":"Adimab (United States)","ror":"https://ror.org/05mk27574","country_code":"US","type":"company","lineage":["https://openalex.org/I4210161061"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Pejchal","raw_affiliation_strings":["LLC","Adimab, LLC, NH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LLC","institution_ids":[]},{"raw_affiliation_string":"Adimab, LLC, NH, USA","institution_ids":["https://openalex.org/I4210161061"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036688663","display_name":"Paul Widboom","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210161061","display_name":"Adimab (United States)","ror":"https://ror.org/05mk27574","country_code":"US","type":"company","lineage":["https://openalex.org/I4210161061"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul F Widboom","raw_affiliation_strings":["LLC","Adimab, LLC, NH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LLC","institution_ids":[]},{"raw_affiliation_string":"Adimab, LLC, NH, USA","institution_ids":["https://openalex.org/I4210161061"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5020741638","display_name":"Michael B. Battles","orcid":"https://orcid.org/0000-0002-5321-7460","observed_orcids":["https://orcid.org/0000-0002-5321-7460"]},"institutions":[{"id":"https://openalex.org/I4210161061","display_name":"Adimab (United States)","ror":"https://ror.org/05mk27574","country_code":"US","type":"company","lineage":["https://openalex.org/I4210161061"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Michael B Battles","raw_affiliation_strings":["LLC","Adimab, LLC, NH, USA"],"raw_orcid":"https://orcid.org/0000-0002-5321-7460","affiliations":[{"raw_affiliation_string":"LLC","institution_ids":[]},{"raw_affiliation_string":"Adimab, LLC, NH, USA","institution_ids":["https://openalex.org/I4210161061"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5020741638"],"corresponding_institution_ids":["https://openalex.org/I4210161061"],"apc_list":{"value":2915,"currency":"GBP","value_usd":3575},"apc_paid":{"value":2915,"currency":"GBP","value_usd":3575},"fwci":3.4614,"has_fulltext":true,"cited_by_count":21,"citation_normalized_percentile":{"value":0.93279098,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"15","issue":"1","first_page":"2189974","last_page":"2189974"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cd3e","display_name":"CD3\u03b5","score":0.7870000004768372},{"id":"https://openalex.org/keywords/anti-cd3-antibody","display_name":"anti-CD3 antibody","score":0.8809999823570251},{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":0.8669999837875366},{"id":"https://openalex.org/keywords/t-cell-engagers","display_name":"T-cell engagers","score":0.996999979019165},{"id":"https://openalex.org/keywords/antibody-engineering","display_name":"antibody engineering","score":0.6060000061988831},{"id":"https://openalex.org/keywords/yeast-surface-display","display_name":"yeast surface display","score":0.5440000295639038},{"id":"https://openalex.org/keywords/antibody-affinity","display_name":"antibody affinity","score":0.5199999809265137},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8190000057220459}],"concepts":[{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.7971537113189697},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.6192801594734192},{"id":"https://openalex.org/C114684123","wikidata":"https://www.wikidata.org/wiki/Q419458","display_name":"CD3","level":4,"score":0.5969054698944092},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4586614966392517},{"id":"https://openalex.org/C3020495827","wikidata":"https://www.wikidata.org/wiki/Q426141","display_name":"Bispecific antibody","level":4,"score":0.4400455355644226},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4222177565097809},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3399112820625305},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.31700509786605835},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.2776741683483124},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.24191606044769287},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.22944030165672302},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.0768747329711914}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008252","descriptor_name":"Macaca fascicularis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016853","descriptor_name":"Muromonab-CD3","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017252","descriptor_name":"CD3 Complex","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018033","descriptor_name":"Antibodies, Bispecific","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1080/19420862.2023.2189974","doi":"https://doi.org/10.1080/19420862.2023.2189974","is_oa":true,"landing_page_url":"https://doi.org/10.1080/19420862.2023.2189974","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/19420862.2023.2189974?needAccess=true&role=button","source":{"id":"https://openalex.org/S169123381","display_name":"mAbs","issn_l":"1942-0862","issn":["1942-0862","1942-0870"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10072072","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10072072","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10072072/pdf/KMAB_15_2189974.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"MAbs","raw_type":"Text"},{"id":"pmid:36991534","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36991534","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:f1b21ad34f5b43b9a091030dc72bba16","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/f1b21ad34f5b43b9a091030dc72bba16","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"mAbs, Vol 15, Iss 1 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1080/19420862.2023.2189974","doi":"https://doi.org/10.1080/19420862.2023.2189974","is_oa":true,"landing_page_url":"https://doi.org/10.1080/19420862.2023.2189974","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/19420862.2023.2189974?needAccess=true&role=button","source":{"id":"https://openalex.org/S169123381","display_name":"mAbs","issn_l":"1942-0862","issn":["1942-0862","1942-0870"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.6240000128746033}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4361276906.pdf","grobid_xml":"https://content.openalex.org/works/W4361276906.grobid-xml"},"referenced_works_count":72,"referenced_works":["https://openalex.org/W1721387010","https://openalex.org/W1906539852","https://openalex.org/W1964944723","https://openalex.org/W1976174066","https://openalex.org/W1978090240","https://openalex.org/W1981981290","https://openalex.org/W1991001030","https://openalex.org/W1991644988","https://openalex.org/W2010801138","https://openalex.org/W2012203161","https://openalex.org/W2016704496","https://openalex.org/W2021160162","https://openalex.org/W2023121198","https://openalex.org/W2048868867","https://openalex.org/W2051710717","https://openalex.org/W2057775533","https://openalex.org/W2069471533","https://openalex.org/W2084949662","https://openalex.org/W2086655007","https://openalex.org/W2092889724","https://openalex.org/W2094731078","https://openalex.org/W2104198642","https://openalex.org/W2110057983","https://openalex.org/W2110808180","https://openalex.org/W2111742915","https://openalex.org/W2112802871","https://openalex.org/W2113266091","https://openalex.org/W2124026197","https://openalex.org/W2126258012","https://openalex.org/W2128724236","https://openalex.org/W2143660875","https://openalex.org/W2144081223","https://openalex.org/W2151693654","https://openalex.org/W2163341755","https://openalex.org/W2167745909","https://openalex.org/W2170179543","https://openalex.org/W2180229411","https://openalex.org/W2319569078","https://openalex.org/W2343191045","https://openalex.org/W2558279374","https://openalex.org/W2565528358","https://openalex.org/W2578029714","https://openalex.org/W2592173429","https://openalex.org/W2610932550","https://openalex.org/W2731784911","https://openalex.org/W2739427485","https://openalex.org/W2776027284","https://openalex.org/W2783911823","https://openalex.org/W2807108195","https://openalex.org/W2899223835","https://openalex.org/W2899237873","https://openalex.org/W2951852411","https://openalex.org/W2971032307","https://openalex.org/W2975542828","https://openalex.org/W2990616783","https://openalex.org/W3016237517","https://openalex.org/W3034816694","https://openalex.org/W3121833403","https://openalex.org/W3129651179","https://openalex.org/W3159583337","https://openalex.org/W3165570177","https://openalex.org/W3169689223","https://openalex.org/W3177547893","https://openalex.org/W3181390667","https://openalex.org/W3213415562","https://openalex.org/W4214927047","https://openalex.org/W4221004774","https://openalex.org/W4225281122","https://openalex.org/W4248872320","https://openalex.org/W4292238158","https://openalex.org/W4308992241","https://openalex.org/W4310875677"],"related_works":["https://openalex.org/W4409645211","https://openalex.org/W4308395446","https://openalex.org/W4385285375","https://openalex.org/W4415900399","https://openalex.org/W2897416090","https://openalex.org/W4282972797","https://openalex.org/W4388068375","https://openalex.org/W2377042068","https://openalex.org/W3181390667","https://openalex.org/W7148954574"],"abstract_inverted_index":{"Bispecific":[0],"antibodies":[1,30,52,112,134,149],"continue":[2],"to":[3,145],"represent":[4],"a":[5,13,38,87,139],"growth":[6],"area":[7],"for":[8,65,125],"antibody":[9,77,84,95],"therapeutics,":[10],"with":[11,33,62,81,97,110,129,143,153],"roughly":[12],"third":[14],"of":[15,47,74,107,118,171],"molecules":[16],"in":[17,79,113],"clinical":[18],"development":[19],"being":[20],"T-cell":[21,172],"engagers":[22],"that":[23,123,163],"use":[24],"an":[25],"anti-CD3":[26],"binding":[27],"arm.":[28],"CD3":[29,48,76,94,111,126,133],"possessing":[31],"cross-reactivity":[32],"cynomolgus":[34],"monkey":[35],"typically":[36],"recognize":[37],"highly":[39],"electronegative":[40],"linear":[41],"epitope":[42],"at":[43],"the":[44,71,114,166],"extreme":[45],"N-terminus":[46],"epsilon":[49],"(CD3\u03b5).":[50],"Such":[51,148],"have":[53,91],"high":[54],"isoelectric":[55],"points":[56],"and":[57,83,101,156,159,168],"display":[58],"problematic":[59],"polyreactivity":[60,100],"(correlated":[61],"poor":[63],"pharmacokinetics":[64],"monospecific":[66],"antibodies).":[67],"Using":[68],"insights":[69],"from":[70],"crystal":[72],"structure":[73],"anti-Hu/Cy":[75],"ADI-26906":[78],"complex":[80],"CD3\u03b5":[82],"engineering":[85,161],"using":[86],"yeast-based":[88],"platform,":[89],"we":[90],"derived":[92],"high-affinity":[93],"variants":[96,109],"very":[98],"low":[99,146],"significantly":[102],"improved":[103,154],"biophysical":[104],"developability.":[105],"Comparison":[106],"these":[108],"clinic":[115],"(as":[116],"part":[117],"bi-":[119],"or":[120],"multi-specifics)":[121],"shows":[122],"affinity":[124,141],"is":[127],"correlated":[128],"polyreactivity.":[130,147],"Our":[131],"engineered":[132],"break":[135],"this":[136],"correlation,":[137],"forming":[138],"broad":[140],"range":[142],"no":[144],"will":[150,164],"enable":[151],"bispecifics":[152],"pharmacokinetic":[155],"safety":[157],"profiles":[158],"suggest":[160],"solutions":[162],"benefit":[165],"large":[167],"growing":[169],"sector":[170],"engagers.":[173]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2023-03-31T00:00:00"}